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Abstract 
Background: Inappropriate prescriptions can lead to adverse consequences for patients. It also imposes excessive 
cost on the patients, payers and health systems. The current study aimed at estimating the rate of inappropriate brain 
Magnetic Resonance Imaging (MRI) prescriptions and their financial burden in Iran.
Methods: Using systematic stratified sampling method, this cross-sectional study recruited 385 participants from 
three public teaching hospitals in Shiraz, Iran. Demographic information, questions related to brain MRI prescrip-
tion and its indications checklist were collected using study-specific data collection tools. The completed indications 
checklist was compared to the appropriateness status table of indications and scenarios to detect the percent of the 
appropriateness of prescriptions.
Results: About 21 percentage of total brain MRI prescriptions are inappropriate. Previous treatment, number of refer-
rals to physician, having other diagnostic tests and the applicant of MRI (P < 0.01) had significant relationships with 
prescription appropriateness. The estimated financial burden of inappropriate brain MRIs in Shiraz teaching hospitals 
was 99,988 US dollar in 2017.
Conclusions: More than one-fifth of brains MRIs were inappropriate (i.e. prescriptions without medical indications). 
It caused 99,988 United States Dollar (USD) financial burden which is 17 times that of Iran’s Gross Domestic Product 
(GDP) per capita. To better allocate resources for the provision of MRI services to health system, rationing policies for 
controlling moral hazard and reducing provider induced demand can be helpful.
Keywords: Magnetic Resonance Imaging, Health Expenditures, Medical Overuse, Unnecessary Procedures, 
Neurology, Prescriptions
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Background
Neurological diseases are one of the common causes of 
death and physical and mental disabilities in different 
societies. Neurological diseases are disorders that influ-
ence the central and peripheral nervous system includ-
ing brain, spinal cord, and nerves such as cerebrovascular 
disease [1]. Early and precise diagnosis of brain and neu-
rological disorders and damages will assist in the better 
and fast treatment of those illnesses. Magnetic Resonance 
Imaging (MRI) have important roles in diagnosing these 
illnesses [2]. In addition to assisting in the early diagnosis 
of illness, imaging prevents more aggressive measures for 
treatment [3]. In this respect, one application of MRI is 
diagnosis of brain and neurological illnesses [4].
It is stated that only less than half of MRIs prescribed 
by neurologists were appropriate [5]. Despite the signifi-
cant effects of MRI in diagnosing diseases, unnecessary 
provision of it can impose financial burden on patients, 
payers and healthcare systems [6, 7].
There is substantial growth in MRI acquisition and uti-
lization in Iran [8]. According to a local research in Iran, 
about 80 percentage of demanded MRIs by physicians for 
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the patients suffering from headache had normal results. 
It shows that MRI prescriptions in many cases are illogi-
cal and inappropriate [9]. According to Salari et al. [10], 
167 lumbar spine MRI prescriptions among 300 pre-
scriptions were inappropriate, and the cost of these inap-
propriate prescriptions was estimated at 7178 US dollar. 
So, health economists and policy makers believe that 
evidence-based and appropriate use of these services 
reduces health services costs and promotes services qual-
ity [5].
According to the last published statistics in Iran in 
2018, total health expenditure (THE) was about 39 bil-
lion United States Dollar (USD) (8.7 percentage of Gross 
Domestic Product (GDP)), which was 484.3 USD in terms 
of per capita. Public spending, including social insurance 
and government budget, accounted for 45.9 percentage 
of THE. Out of pocket payments as the main source of 
health financing accounted for 35.8 percentage of THE 
[11]. In an unpublished study in Iran, it is reported that 
MRI services cost that covered by insurance organiza-
tions (both social and private) was about 6.8 million USD 
in 2018 [12]. Anyway, as mentioned by other researchers, 
advanced diagnostic procedures such as MRI are speci-
fied as main drivers of the health care expenditure [13, 
14].
The present study aimed to evaluate the level of brain 
MRI inappropriate prescriptions and their financial bur-
den in public teaching hospitals in Shiraz in 2017.
Methods
This research is a cross-sectional study that was car-
ried out in 2017 to evaluate the level of inappropriate 
prescriptions of brain MRIs and their financial burden 
in teaching hospitals of Shiraz University of Medical 
Sciences.
Using systematic stratified sampling method, this 
research recruited 385 participants from public teaching 
hospitals in Shiraz, Iran.
The total sample size was proportionally allocated 
to three public hospitals namely, Namazi, Faghihi, and 
Chamran, which were the only MRI services providers in 
Shiraz’s public sector, according to their volume of MRI 
services.
To select participants in each hospital, the waiting list 
of patients was obtained from the hospitals’ MRI depart-
ments, and the participants were randomly selected using 
random number tables.
To collect data, one nurse attended in patients’ readi-
ness rooms and examined the prescriptions of the 
patients who were selected previously through a system-
atic sampling from the waiting list of MRI. We exclude 
the prescriptions that did not have a patient history or 
MRI prescriptions that have not registered.
The selected participant’s information was collected 
through a data collection form. This form consisted of 
two parts. The first part was about patients’ demographic 
information and the questions related to prescription and 
the second part was the brain MRI prescription indica-
tions checklist. We used the checklist that was developed 
by Salari et al. [15].
The data obtained from data collection forms was 
compared to the appropriateness status table of indica-
tions and scenarios to detect the percentage of the pre-
scriptions’ appropriateness. Salari et  al. developed these 
indications and scenarios appropriateness status table. 
In that consensus-based study, experts in brain disorders 
(neurosurgeons and neurologists) scored the scenarios 
according to Rand Appropriateness Method. The sce-
narios were classified into the categories of appropriate, 
uncertain and inappropriate [15].
To estimate the number of inappropriate MRI prescrip-
tions, the estimated rate of inappropriateness of brain 
MRI was multiplied by total brain MRI services provided 
by public hospitals in Shiraz. Finally, by multiplying the 
number of inappropriate prescriptions by the brain MRI 
procedure’s tariffs for the patient and insurer in 2017 the 
overall imposed financial burden was estimated. It should 
be noted that in the current study the financial costs of 
inappropriate MRI were estimated and the comprehen-
sive economic burden of them was not studied. For con-
verting Iranian Rial to USD exchange rate reported by the 
central bank of Iran was used [16]. Statistical analysis was 
performed by Stata 14.
Results
About 60 percentage of patients were female and 96 per-
centage have basic health insurance. The education level 
of patients was elementary and secondary (33.2), aca-
demic (28.7), high school diploma (25.5) and illiterate 
(13.5), respectively. 37 percentage of patient had comple-
mentary health insurance.
Table 1 shows descriptive statistics of the appropriate-
ness status of brain MRI in studied patients and the rela-
tionship between examined patients’ socio-demographic 
variables with the appropriateness of brain MRI descrip-
tions. The results indicate that generally 21.6 percentage 
of total prescriptions are not appropriate.
Table  2 also indicates the mentioned statistics based 
on clinical variables. Results demonstrated that previ-
ous treatment, number of times of visit, having other 
diagnostic tests and the applicant of MRI (P < 0.01), 
type of treatment and the specialty of the physician 
(P < 0.1), had significant relationships with prescriptions 
appropriateness.
Among 16,200 brain MRIs that were done in studied 
(three) hospitals in 2017, 21.6 percentage, it means 3500 
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cases were brain MRIs without indication, among which 
2240 cases (64 percentage) were with injection and 1260 
cases (36 percentage) were with and without injection. 
The tariffs of doing a brain MRI procedure without injec-
tion was 22.7 USD and the tariffs of doing a brain MRI 
procedure with and without injection was 39 USD in 
2017.
So the financial burden of inappropriate brain MRIs 
on the patients and insurers for “without injection”, “with 
and without injection” and all MRIs were 50 848, 49,140 
and 99,988 USD, respectively (Table 3).
Discussion
Inappropriate prescriptions for MRI services can lead to 
an adverse outcome for patients and imposes an excessive 
cost on the patients and health systems. So the appropri-
ateness of brain MRI prescriptions, its related factors and 
financial burden were investigated in this study.
Findings show that 21.6 percentage of brain MRI 
prescriptions were without indication (inappropriate). 
Researches that mainly assessed the brain MRI appro-
priateness are few, so other MRI services are also com-
pared with our findings. Piersson et  al. [17] reported 
that about 19 percentage of brain MRIs in a single 
center in Ghana were inappropriate. It seems the use of 
MRI procedure in Iran is similar to that of the United 
States of America (USA), which has a very costly health 
system; because Lehnert & Bree (2010) found that 26 
percentage of MRI and Computerized Tomography 
(CT) scan prescriptions in the USA are inappropriate 
[18]. Oikarinen et  al. [19] indicated that 7 percentage 
of MRIs done in an academic hospital in Finland were 
inappropriate. Saadat et  al. [20] found that 17.2 per-
centage of conducted MRIs in private centers in Teh-
ran were normal that 9.8 percentage of them were for 
headache examinations. Barzin et  al. demonstrated 
that 81 percentage of requested MRIs by physicians 
for patients suffering from headaches in an educational 
hospital in Sari city had normal results [9]. Sheehan 
et  al. [21] reported that 45 percentage (106 cases) out 
of 237 prescribed MRIs for shoulder in a department 
of veterans affairs tertiary care hospital were inappro-
priate. In recent research in Ontario, the inappropriate 
rate of hip MRI is estimated at 32.1 percentage [22].
The Comparison also shows that there are different 
results on different MRI services (all MRI, brain, shoul-
der, hip, …). There are also different inappropriate rate 
of MRI prescriptions across different countries and 
settings associated with their health system structure 
and policies to control physician and patient behavior. 
However, it seems these differences should be mainly 
Table 1 Appropriateness of  brain MRI prescriptions based on  patients’ socio-demographic variables in  Shiraz public 
hospitals in 2017
Overall With indication Without indication Total P-value
Frequency Percent Frequency Percent Frequency Percent
302 78.45 83 21.55 385 100
Gender Male 116 76.82 35 23.18 151 100 0.535
Female 186 79.5 48 20.5 234 100
Education level Illiterate 39 75 13 25 52 100 0.094
Elementary & secondary 105 82 23 18 128 100
High school diploma 82 83.67 16 16.33 98 100
Academic 76 71 31 29 107 100
Job Employee 53 76.81 16 23.89 69 100 0.949
Worker 38 79.17 10 20.83 48 100
Housewife 126 79.24 33 20.76 159 100
Self-employed 65 76.47 20 23.53 85 100
Other 20 83.34 4 16.66 24 100
Basic insurance status Not insured 11 84.61 2 15.39 13 100 0.743
Insured 291 78.22 81 21.78 372 100
Insurer Social security organization 128 81 30 19 158 100 0.211
Iran health insurance organization 143 78 40 22 183 100
Armed forces insurance organization 10 66.6 5 33.4 15 100
Other insurers 10 62.5 6 37.5 16 100
Complementary insur-
ance coverage
Yes 81 77.88 23 22.12 104 100 0.921
No 221 78.64 60 21.36 281 100
Page 4 of 6Kavosi et al. Cost Eff Resour Alloc           (2021) 19:14 
explained by different methodology, indications crite-
ria, and instruments used by different researchers.
Analytic findings show that there are no significant 
relationships between socio-demographic variables and 
brain MRI appropriateness. However, several clinical fac-
tors have a significant relationship with the appropriate-
ness of brain MRI.
We found that having previous treatment and other 
diagnostic tests are related to brain MRI’s appropri-
ateness. Manta [22] showed that having no previous 
radiographic examination was the most predictor of 
inappropriate prescription of hip MRI in Ontario.
Also, Sheehan et al. [21] showed that ultrasound could 
be a cost-saving substitution for 66 percentage of shoul-
der MRIs.
Finding also indicates that 27.74 percentage of 191 
patients at the first visit to the physicians were without 
indication for brain MRI. We also found the more num-
ber of times a patient visits a physician, the less likely the 
inappropriateness of brain MRI. Patients with more visits 
to doctors likely have chronic and severe symptoms [23], 
so their MRIs probably are necessary and appropriate. It 
also can be explained by defensive medicine. In the first 
visit, physicians reduce and compensate for malpractice 
liability risk and apply more tests and treatments, which 
may be unnecessary [24].
One of the main results is that the primary applicant 
of MRI has a significant relationship with brain MRI’s 
appropriateness. About 19 percentage of prescriptions 
requested primarily by physicians were inappropriate, 
but on the contrary, more than 60 percentage of brain 
MRIs requested primarily by patients were inappropriate. 
Table 2 Appropriateness of brain MRI prescriptions based on clinical variables in Shiraz public hospitals in 2017
a CT scan, electroencephalography, etc
Overall With indication Without indication Total P-value
Frequency Percent Frequency Percent Frequency Percent
302 78.45 83 21.55 385 100
Having previous treatment Yes 115 68.86 52 31.14 167 100 0.001
No 187 85.78 31 14.22 218 100
Type of treatment Drug 137 84.05 26 15.95 163 100 0.068
Rest 6 75 2 25 8 100
Surgery 42 95.45 2 4.55 44 100
Others 2 66.67 1 33.33 3 100
Treatment duration Less than 1 Year 59 78.67 16 21.33 75 100 0.112
1–5 years 73 86.90 11 13.10 84 100
More than 5 Years 55 93.22 4 6.78 59 100
Number of times of visit First time 138 72.25 53 27.74 191 100 0.001
Second times 68 75.56 22 24.44 90 100
Third times or more 96 92.3 8 7.7 104 100
Having other diagnostic  testsa Yes 159 85.48 27 14.52 186 100 0.001
No 143 71.86 56 28.14 199 100
Applicant Physician 279 80.63 67 19.37 346 100 0.001
Patient 6 37.5 10 62.5 16 100
Physician & patient 17 73.91 6 26.09 23 100
Referral center Public hospital 194 79.83 49 20.17 243 100 0.254
Private hospital 20 66.67 10 33.33 30 100
Private office 88 78.57 24 21.43 112 100
Specialty of the physician Neurosurgery 78 80.41 19 19.59 97 100 0.064
Neurologist 123 67.95 58 32.05 181 100
Other 101 94.39 6 5.61 107 100
Table 3 Financial burden of  inappropriate brain MRIs 








Without injection 2240 22.7 50,848
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Patients usually appeal diagnostic tests e.g., MRI from 
their physician; however, many times, their request is 
unnecessary. Although it likely increases patients’ sat-
isfaction and health outcomes, it wastes health system 
resources and maybe increases the side effects of these 
tests [25]. It is also related to the consumer moral hazard 
concept, resulting from information asymmetry between 
purchasers and patients [26].
Some macro factors which can affect on volume of 
unnecessary diagnostic tests and interventions that we 
could not assess their effect. For example, Andrade et al. 
found that more supply of imaging services (imaging 
centers, MRI machines, radiologists) by itself increase 
the demand for such services [27]. This phenomenon can 
be explained by provider induced demand or more acces-
sibility to these services.
The present study showed that the financial burden 
resulting from inappropriate brain MRI prescriptions in 
2017 was 99,988 USD in Shiraz public hospitals, which is 
about 17 times of Iran’s GDP per capita in that year (5680 
USD) [28]. This financial burden is related to one type 
of MRI services (brain MRI), in one city and only pub-
lic centers. Considering all the mentioned factors, there 
is a noticeable financial burden of inappropriate MRI 
services in Iran. It should be asserted that according to a 
national study in 2018, there were 276 MRI machines in 
Iran (about 3.5 per one million population) [29].
There are few studies with a focus on Brain MRI. More-
over, different studies have utilized different tools for 
checking the appropriateness of MRI services, and finally, 
there are different approaches to estimate the financial/
economic burden. As we estimated only the direct finan-
cial burden of inappropriate brain MRI services, it is not 
compared with other areas.
A major limitation of the current study is that there are 
not clear statistics about the utilization of brain MRI in 
Iran, so we cannot estimate the overall financial burden 
of brain MRI in Iran. We only estimated the financial bur-
den of brain MRI in public hospitals in Shiraz. Another 
main limitation is that we calculated the only direct 
medical financial costs of inappropriate brain MRI and 
comprehensive economic burden of them (such as trans-
portation cost, food cost, productivity loss and intangible 
cost) was not studied. Moreover, the lack of similar stud-
ies on brain MRI, relevant factors and its financial burden 
was another limitation.
Conclusions
About one-fourth of brains MRIs were inappropriate. It 
caused 99,988 USD financial burden which is 17 times 
of Iran’s GDP per capita. To better allocation of health 
system resources for the provision of MRI services, 
rationing policies for controlling consumer moral hazard 
and reducing provider induced demand can be helpful.
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